Ropes & Gray-Led Pharma Biz Offers $541M For Swedish Rival
U.S. biopharma company ANI said Thursday it has offered to acquire Swedish pharmaceutical company Egetis for up to approximately 5.3 billion Swedish kronor ($541 million) to gain access to a newly...To view the full article, register now.
Already a subscriber? Click here to view full article